A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions
Clinical trial NCT06357910 · COMPLETED
Trial details
- NCT number
- NCT06357910
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-17
- Primary completion
- 2024-07-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.